Le Lézard
Classified in: Health, Business
Subject: TNM

GI Partners and TA Associates to Acquire Allscripts' stake in Netsmart Technologies


SAN FRANCISCO, Dec. 10, 2018 /PRNewswire/ -- GI Partners ("GI"), a leading private equity firm, together with TA Associates ("TA") announced today that it has signed a definitive agreement to acquire the stake held in Netsmart Technologies, Inc. ("Netsmart") by Allscripts Healthcare Solutions, Inc. (NASDAQ: MDRX). This transaction represents an additional investment for GI Partners over its initial stake acquired in April 2016, and results in majority ownership of Netsmart by GI Partners. This transaction will further build out Netsmart as the leading provider of human services and post-acute technology in healthcare.

(PRNewsfoto/GI Partners)

Founded in 1968, Netsmart is the leading provider of software and technology solutions designed especially for the health and human services and post-acute sectors, enabling mission-critical clinical and business processes including electronic health records, population health, billing, analytics and health information exchange. Since GI Partners' investment in 2016, Netsmart has experienced considerable growth through product innovation and multiple strategic acquisitions. During this time, Netsmart launched myUnity, the only multi-tenant SaaS platform serving the entire post-acute care continuum, and successfully completed strategic acquisitions in human services and post-acute care technology. Over the same period, Netsmart has added 150,000 users and over 5,000 organizations to its platform.

Dave Kreter, Managing Director of GI Partners, said, "We thank Allscripts for their partnership and look forward to the next chapter of growth with our new partners, TA Associates. We are excited to support management as they continue down the path of making Netsmart the largest HCIT provider outside of the hospital walls."

Howard Park, Managing Director of GI Partners, said, "We continue to strongly believe Netsmart represents an attractive business that aligns with our focus on healthcare, IT infrastructure, and software. We are excited to work with the company and TA to focus on the next phase of growth for the business."

Mike Valentine, Chief Executive Officer of Netsmart, who will continue in that capacity, said, "The GI and TA teams have substantial relevant investing and operating experience in the end-markets and industries in which Netsmart serves. We look forward to our continued partnership with GI and new relationship with TA for the next chapter of growth."

The transaction is subject to customary closing conditions and is expected to be completed in December 2018.

J.P. Morgan Securities LLC and Evercore acted as financial advisors to Allscripts and Sidley Austin provided legal counsel. Paul Hastings provided legal counsel to GI Partners. Kirkland & Ellis provided legal counsel to TA Associates.

About Netsmart
Netsmart develops electronic health records (EHRs), solutions and services that are powerful, intuitive and easy-to-use. Its platform provides accurate, up-to-date information which is easily accessible to care team members in behavioral health, care at home, senior living and social services. Netsmart employs over 1,700 associates to work hand-in-hand with its 600,000+ users in more than 25,000 organizations across all 50 states in the U.S. to develop and deploy technology that automates and coordinates everything from clinical to financial to administrative.

About GI Partners
GI Partners is a private investment firm based in San Francisco. The firm has raised over $17 billion in capital from leading institutional investors around the world. GI Partners' private equity team focuses on investments in the Healthcare, IT Infrastructure, Services, and Software sectors. For more information on GI Partners and its entire portfolio, please visit www.gipartners.com.

Media Contacts:


Chris Tofalli                                          

Gretchen Robinson

Chris Tofalli Public Relations LLC             

GI Partners Investor Relations

914-834-4334                                           

415-688-4866

[email protected]                                  

[email protected]

 

SOURCE GI Partners


These press releases may also interest you

at 22:18
The report titled "Personalized Nutrition Market by Measurement Type (Active Measurement, Standard Measurement), Application (Indication-based, Standard Supplements), Distribution Channel, End-Use - Global Forecast 2024-2030" is now available on...

at 22:03
The report titled "Carbon Dioxide Incubator Market by Product (Air Jacketed CO2 Incubators, Direct Heat CO2 Incubators, Water Jacketed CO2 Incubators), Capacity (100-200 Litre, Above 200 Litre, Below 100 Litre), Application, End User - Global...

at 22:00
The "Global Clinical In Vitro Diagnostic Medical Laboratory Services Market: Strategy & Trends with Volume & Price Forecasts by Chemistry, Hematology, Microbiology, Pathology, Covid-19, and Molecular Dx by Country. Updated with Impact of COVID-19"...

at 21:45
The "Molecular Diagnostics at the Point of Care. By Application, Technology, Place, Product and by Country. With Executive Guides and Customization 2023 - 2027 " report has been added to  ResearchAndMarkets.com's offering. Infectious disease Dx is...

at 21:30
The "Whole Genome and Exome Sequencing Markets by Application, Organism and Product with Executive and Consultant Guides. Includes Direct to Consumer Analysis. 2023 to 2027" report has been added to  ResearchAndMarkets.com's offering. Will all...

at 20:50
Pharma (1167.HK), a clinical-stage oncology company drugging the undruggable targets, today announced its 2023 annual results. The revenue was RMB63.5 million, the R&D investment was RMB372 million, the cash and cash equivalent at the end of 2023 was...



News published on and distributed by: